Cargando…
Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
Castration-resistant prostate cancer (CRPC) is a common form of prostate cancer in which docetaxel-based chemotherapy is used as the first line. The present study is devoted to the analysis of transcriptome profiles of tumor cells in the development of resistance to docetaxel as well as to the asses...
Autores principales: | Pudova, Elena, Kobelyatskaya, Anastasiya, Katunina, Irina, Snezhkina, Anastasiya, Nyushko, Kirill, Fedorova, Maria, Pavlov, Vladislav, Bulavkina, Elizaveta, Dalina, Alexandra, Tkachev, Sergey, Alekseev, Boris, Krasnov, George, Volodin, Vsevolod, Kudryavtseva, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658696/ https://www.ncbi.nlm.nih.gov/pubmed/36361635 http://dx.doi.org/10.3390/ijms232112837 |
Ejemplares similares
-
Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2023) -
Somatic Mutation Profiling in Head and Neck Paragangliomas
por: Savvateeva, Maria, et al.
Publicado: (2022) -
Comprehensive Genetic Study of Malignant Cervical Paraganglioma
por: Snezhkina, Anastasiya, et al.
Publicado: (2023) -
Differentially methylated CpG sites associated with the high-risk group of prostate cancer
por: Kobelyatskaya, Anastasiya, et al.
Publicado: (2020) -
ALDH3A2, ODF2, QSOX2, and MicroRNA-503-5p Expression to Forecast Recurrence in TMPRSS2-ERG-Positive Prostate Cancer
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2022)